Tag: Developmental Therapeutics and Immuno-Oncology
-
Internationally recognized oncology drug development leader and melanoma expert joins HonorHealth Research Institute
Dr. Nageatte Ibrahim helped guide the clinical development of Keytruda, one of the most consequential immuno-oncology therapies SCOTTSDALE, Ariz. — May 12, 2026 — Nageatte Ibrahim, M.D., an internationally recognized […]
